Concept:
The chemical structure shown belongs to the class of anticholinesterase agents used to manage neurodegenerative disorders. Specifically, this structural configuration is the identity map of Rivastigmine, a reversible acetylcholinesterase inhibitor used to treat mild-to-moderate dementia associated with Alzheimer's disease and Parkinson's disease.
Let us break down the specific components of the illustrated molecular structure:
• The Carbamate Moiety: The structure contains an ester linkage coupled directly to an amine group via a carbonyl spacer (\(-\text{O}-\text{C}(=\text{O})-\text{N}-\)). This specific group is an ethyl(methyl)carbamoyl function, where the carbamate nitrogen is substituted with one methyl group and one ethyl group.
• The Aromatic Core: A central benzene ring serves as the base platform, providing a meta-substitution pattern.
• The Aliphatic Amine Branch: Meta to the carbamate function, there is an ethyl chain branched with a chiral methyl group and terminated by a dimethylamino group (\(-\text{CH}(\text{CH}_3)\text{N}(\text{CH}_3)_2\)).
Let us evaluate the other options to rule them out based on structure:
• Option (A) edrophonium: Edrophonium is a simple quaternary ammonium compound. It lacks a carbamate functional group entirely, consisting of a phenol ring substituted with an ethyl and two methyl groups on a charged nitrogen.
• Option (C) neostigmine: Neostigmine is also a carbamate-based cholinesterase inhibitor, but it contains a dimethylcarbamoyl group and a permanently charged quaternary ammonium group attached to the ring. The structure in the question features a tertiary amine and lacks a permanent positive charge, distinguishing it as rivastigmine.
• Option (D) tabun: Tabun is an organophosphorus compound used as a nerve agent. Its structure features a central phosphorus atom linked to a cyano group, a dimethylamino group, and an ethoxy group, which does not resemble this carbamate structure.
Conclusion: The presence of the uncharged tertiary amine side chain and the unsymmetrical ethyl-methyl carbamate group confirms the molecule is Rivastigmine.